Andon Health Co., Ltd.
SZSE:002432.SZ
34.97 (CNY) • At close October 26, 2023
Overzicht | Financiële gegevens
Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) CNY.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Omzet
| 3,186.377 | 26,315.361 | 2,397.098 | 2,008.36 | 706.276 | 563.88 | 597.919 | 420.138 | 397.858 | 425.452 | 407.567 | 356.082 | 354.132 | 298.702 | 313.158 | 279.505 | 216.942 |
| Kosten van de omzet
| 1,238.229 | 5,367.195 | 875.549 | 877.505 | 502.937 | 394.942 | 414.893 | 284.355 | 295.563 | 292.619 | 274.701 | 237.331 | 235.935 | 196.93 | 207.698 | 194.961 | 139.022 |
| Brutowinst
| 1,948.148 | 20,948.166 | 1,521.548 | 1,130.855 | 203.34 | 168.938 | 183.026 | 135.783 | 102.295 | 132.833 | 132.866 | 118.751 | 118.196 | 101.771 | 105.46 | 84.544 | 77.921 |
| Brutowinstmarge
| 0.611 | 0.796 | 0.635 | 0.563 | 0.288 | 0.3 | 0.306 | 0.323 | 0.257 | 0.312 | 0.326 | 0.333 | 0.334 | 0.341 | 0.337 | 0.302 | 0.359 |
| Onderzoek- en ontwikkelingskosten
| 263.69 | 264.889 | 66.731 | 76.545 | 80.034 | 68.864 | 94.064 | 41.466 | 43.651 | 9.145 | 8.494 | 8.117 | 9.657 | 8.288 | 0 | 0 | 0 |
| Algemene en administratieve kosten
| 207.629 | 520.415 | 98.485 | 66.148 | 68.275 | 54.943 | 60.968 | 50.341 | 32.257 | 27.887 | 14.553 | 7.768 | 7.399 | 13.541 | 41.911 | 32.046 | 20.247 |
| Verkoop- en marketingkosten
| 440.577 | 1,055.742 | 243.466 | 369.907 | 108.458 | 62.051 | 70.578 | 80.332 | 64.137 | 92.946 | 73.319 | 57.202 | 48.467 | 33.738 | 17.503 | 16.858 | 13.797 |
| Verkoop-, algemene en administratieve kosten
| 806.255 | 1,576.158 | 341.951 | 436.055 | 176.733 | 116.994 | 131.546 | 130.673 | 96.394 | 120.833 | 87.872 | 64.97 | 55.866 | 47.279 | 59.414 | 48.904 | 34.044 |
| Overige kosten
| -128.69 | 430.911 | 151.098 | 147.333 | 96.042 | 86.992 | 6.882 | 4.416 | 0.126 | 2.792 | 2.755 | 0.65 | 0.394 | 3.986 | 1.009 | -0.367 | 0.395 |
| Bedrijfskosten
| 1,198.634 | 2,271.957 | 559.78 | 659.932 | 352.809 | 282.848 | 349.622 | 268.663 | 232.239 | 215.825 | 148.489 | 126.507 | 108.326 | 83.106 | 59.414 | 48.904 | 34.044 |
| Bedrijfsresultaat
| 749.514 | 18,311.869 | 1,002.549 | 777.797 | -149.47 | -91.922 | -171.321 | 8.216 | -153.196 | 20.313 | -10.732 | 6.074 | 23.981 | 23.398 | 44.217 | 35.933 | 47.112 |
| Bedrijfsresultaat ratio
| 0.235 | 0.696 | 0.418 | 0.387 | -0.212 | -0.163 | -0.287 | 0.02 | -0.385 | 0.048 | -0.026 | 0.017 | 0.068 | 0.078 | 0.141 | 0.129 | 0.217 |
| Totaal overige inkomsten en kosten netto
| 832.51 | -54.012 | -2.917 | -538.044 | 167.851 | 108.979 | 9.086 | 145.503 | -23.126 | 92.918 | 7.644 | 14.501 | 14.504 | 8.719 | -0.819 | -0.075 | 3.631 |
| Inkomen voor belasting
| 1,582.023 | 18,257.857 | 999.632 | 239.753 | 18.382 | -4.93 | -157.51 | 12.622 | -153.07 | 9.927 | -7.979 | 6.745 | 24.375 | 27.384 | 45.226 | 35.565 | 47.507 |
| Inkomen voor belasting ratio
| 0.496 | 0.694 | 0.417 | 0.119 | 0.026 | -0.009 | -0.263 | 0.03 | -0.385 | 0.023 | -0.02 | 0.019 | 0.069 | 0.092 | 0.144 | 0.127 | 0.219 |
| Belastingkosten
| 231.112 | 1,773.763 | 65.229 | 2.925 | -8.678 | -2.071 | 8.361 | -1.876 | -2.309 | 1.534 | 1.383 | -0.208 | 3.568 | 3.668 | 6.185 | 4.261 | 3.602 |
| Nettowinst
| 1,251.608 | 16,030.169 | 908.642 | 242.329 | 27.06 | 12.687 | -165.861 | 14.498 | -150.761 | 10.198 | -9.168 | 6.983 | 20.807 | 23.716 | 39.041 | 31.304 | 43.905 |
| Nettowinstmarge
| 0.393 | 0.609 | 0.379 | 0.121 | 0.038 | 0.022 | -0.277 | 0.035 | -0.379 | 0.024 | -0.022 | 0.02 | 0.059 | 0.079 | 0.125 | 0.112 | 0.202 |
| WPA (Winst Per Aandeel)
| 2.8 | 35.14 | 2 | 0.56 | 0.063 | 0.03 | -0.38 | 0.04 | -0.41 | 0.03 | -0.02 | 0.02 | 0.053 | 0.073 | 0.14 | 0.11 | 0.15 |
| Verwaterde WPA
| 2.77 | 34.3 | 2 | 0.56 | 0.063 | 0.03 | -0.38 | 0.04 | -0.41 | 0.03 | -0.02 | 0.02 | 0.053 | 0.073 | 0.14 | 0.11 | 0.15 |
| EBITDA
| 857.134 | 19,035.632 | 1,106.312 | 840.574 | -83.46 | 159.974 | -87.801 | 52.023 | -118.962 | 48.73 | 10.977 | 16.249 | 30.677 | 32.697 | 49.258 | 36.923 | 44.741 |
| EBITDA ratio
| 0.269 | 0.723 | 0.462 | 0.419 | -0.118 | 0.284 | -0.147 | 0.124 | -0.299 | 0.115 | 0.027 | 0.046 | 0.087 | 0.109 | 0.157 | 0.132 | 0.206 |